Diagnostic usefulness of cognitive auditory event-related P300 subcomponents in patients with Alzheimers disease?

被引:46
作者
Juckel, Georg [1 ,2 ]
Clotz, Frauke [2 ]
Frodl, Thomas [2 ]
Kawohl, Wolfram [3 ]
Hampel, Harald [4 ,5 ]
Pogarell, Oliver [2 ]
Hegerl, Ulrich [2 ,6 ]
机构
[1] Ruhr Univ Bochum, Dept Psychiat, D-44791 Bochum, Germany
[2] Univ Munich, Dept Psychiat, Clin Neurophysiol Sect, D-8000 Munich, Germany
[3] Univ Zurich Hosp, Res Grp Clin & Expt Psychopathol, CH-8091 Zurich, Switzerland
[4] Univ Munich, Alzheimer Mem Ctr, Geriatr Psychiat Branch, Munich, Germany
[5] Univ Munich, Dept Psychiat, Dementia Res Sect, D-8000 Munich, Germany
[6] Univ Leipzig, Dept Psychiat & Psychotherapy, Leipzig, Germany
关键词
Alzheimer disease; P300; event-related; cholinergic function; early recognition;
D O I
10.1097/WNP.0b013e3181727c95
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Early diagnosis of Alzheimers disease (AD) would be of great clinical value. Auditory event-related P300 mainly generated in temporoparietal regions is related to the pathophysiology of AD. A former study revealed that reliable separation of P300 subcomponents by dipole source analysis increased sensitivity (86.7%) and specificity (76.7%) in correctly detecting AD patients from healthy subjects. Aim of the present study was to replicate this interesting finding on a different sample. Auditory event-related P300 was recorded in unmedicated patients with mild to moderate AD and age- and sex-matched healthy volunteers. The subcomponents of the P300, P3a and P3b, were determined by dipole source analysis (Brain Electric Source Analysis program). As in the first study, AD patients were again characterized by a diminished P3b amplitude and longer P3a latency and reaction time. Using these three parameters, sensitivity was 81.3% to detect patients with AD from healthy controls with a specificity of 83.3%. This successful replication of the first study suggests that recording and determining P300 subcomponents together with other putative neurobiological markers may be useful to enhance the individual diagnostic accuracy in AD at an early stage.
引用
收藏
页码:147 / 152
页数:6
相关论文
共 50 条
[1]  
Almkvist O, 1999, EUR ARCH PSY CLIN N, V249, P3
[2]   Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease:: a community based follow up study [J].
Andreasen, N ;
Vanmechelen, E ;
Van de Voorde, A ;
Davidsson, P ;
Hesse, C ;
Tarvonen, S ;
Räihä, I ;
Sourander, L ;
Winblad, B ;
Blennow, K .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 64 (03) :298-305
[3]   Evaluation of CSF-tau and CSF-Aβ42 as diagnostic markers for Alzheimer disease in clinical practice [J].
Andreasen, N ;
Minthon, L ;
Davidsson, P ;
Vanmechelen, E ;
Vanderstichele, H ;
Winblad, B ;
Blennow, K .
ARCHIVES OF NEUROLOGY, 2001, 58 (03) :373-379
[4]   Advances in the treatment of Alzheimer's disease: Benefits of dual cholinesterase inhibition [J].
Ballard, CG .
EUROPEAN NEUROLOGY, 2002, 47 (01) :64-70
[5]  
Bickel H, 2001, Z GERONTOL GERIATR, V34, P108, DOI 10.1007/s003910170074
[6]   P300, a state and a trait marker in schizophrenia [J].
Blackwood, D .
LANCET, 2000, 355 (9206) :771-772
[7]   EVENT-RELATED POTENTIALS AND PSYCHOPHARMACOLOGY - CHOLINERGIC MODULATION OF P300 [J].
DIERKS, T ;
FROLICH, L ;
IHL, R ;
MAURER, K .
PHARMACOPSYCHIATRY, 1994, 27 (02) :72-74
[8]   IS THE P300 COMPONENT A MANIFESTATION OF CONTEXT UPDATING [J].
DONCHIN, E ;
COLES, MGH .
BEHAVIORAL AND BRAIN SCIENCES, 1988, 11 (03) :357-374
[9]  
Fisch BJ, 1999, FISCH SPEHLMANNS EEG
[10]   MINI-MENTAL STATE - PRACTICAL METHOD FOR GRADING COGNITIVE STATE OF PATIENTS FOR CLINICIAN [J].
FOLSTEIN, MF ;
FOLSTEIN, SE ;
MCHUGH, PR .
JOURNAL OF PSYCHIATRIC RESEARCH, 1975, 12 (03) :189-198